Development of a delayed-release nutrient for appetite control in adults with obesity and type 2 diabetes and initial clinical testing in a single dose randomized controlled trial

DOI: 10.1038/s41387-019-0088-7

Keywords: Drug development, Translational research

Full-Text   Cite this paper   Add to My Lib

Abstract:

Composition of administered delayed-release nutrient (DRN) and unformulated nutrient (UN

Full-Text